Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - TOTAL ASSETS
Total Assets URGN - UroGen Pharma Ltd.
178 M
LAST VALUE
22.03%
2 YEAR CAGR
11.48%
5 YEAR CAGR
49.37%
10 YEAR CAGR